サマリー

シクロオキシゲナーゼ阻害作用を有する非ステロイド性抗炎症剤（NSAID）で、関節リウマチや変形性関節症の治療に定評があり、筋骨格系疾患、月経困難症、術後の疼痛などに使用されています。半減期が長いことから、1日1回の投与が可能です。

市場分析と洞察。ピロキシカムの世界市場
Piroxicamの世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータ整合性により、世界のPiroxicam市場で入手可能な主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、収益面でのPiroxicamの世界市場全体のサイズを含む、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のPiroxicam市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のPiroxicam市場を詳細に調査するために、独自の、そして業界で最も優れた調査・分析手法を用いています。

世界のPiroxicamの範囲と市場規模
Piroxicam市場は、企業別、地域（国）別、タイプ別、用途別に分類されています。世界のPiroxicam市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
剤形別
坐薬
注射剤
カプセル
パッチ
その他
経路別
経口
直腸

用途別セグメント
腱鞘炎
全身性外傷性疼痛
筋骨格の痛み
避妊具
リューマチ性関節炎
慢性感染性関節炎
変形性関節症
その他

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ファイザー
Teva
マイラン
ノストラム
DCPC
方明(FANGMING)
JINGHUA
JUMPCAN
テクニラブ・ファーマ
アポテックス・コーポレーション
ケルトマン・ファーマシューティカルズ
Genpharm社
バイエル
PLXファーマ
キエーシ
SKケミカルズ
バイオグラン・ラボラトリーズ
APR
CJヘルスケア
SkyePharma
常州市のシヤオ製薬
山西雲鵬製薬

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Piroxicam Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Suppositories
1.2.3 Injection
1.2.4 Capsule
1.2.5 Patch
1.2.6 Other
1.3 Market by Application
1.3.1 Global Piroxicam Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tendonitis
1.3.3 Systemic Traumatic Pain
1.3.4 Musculoskeletal Pain
1.3.5 Contraception
1.3.6 Rheumatoid Arthritis
1.3.7 Chronic Infectious Arthritis
1.3.8 Osteoarthritis
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Piroxicam Market Perspective (2016-2027)
2.2 Piroxicam Growth Trends by Regions
2.2.1 Piroxicam Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Piroxicam Historic Market Share by Regions (2016-2021)
2.2.3 Piroxicam Forecasted Market Size by Regions (2022-2027)
2.3 Piroxicam Industry Dynamic
2.3.1 Piroxicam Market Trends
2.3.2 Piroxicam Market Drivers
2.3.3 Piroxicam Market Challenges
2.3.4 Piroxicam Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Piroxicam Players by Revenue
3.1.1 Global Top Piroxicam Players by Revenue (2016-2021)
3.1.2 Global Piroxicam Revenue Market Share by Players (2016-2021)
3.2 Global Piroxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Piroxicam Revenue
3.4 Global Piroxicam Market Concentration Ratio
3.4.1 Global Piroxicam Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Piroxicam Revenue in 2020
3.5 Piroxicam Key Players Head office and Area Served
3.6 Key Players Piroxicam Product Solution and Service
3.7 Date of Enter into Piroxicam Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Piroxicam Breakdown Data by Type
4.1 Global Piroxicam Historic Market Size by Type (2016-2021)
4.2 Global Piroxicam Forecasted Market Size by Type (2022-2027)

5 Piroxicam Breakdown Data by Application
5.1 Global Piroxicam Historic Market Size by Application (2016-2021)
5.2 Global Piroxicam Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Piroxicam Market Size (2016-2027)
6.2 North America Piroxicam Market Size by Type
6.2.1 North America Piroxicam Market Size by Type (2016-2021)
6.2.2 North America Piroxicam Market Size by Type (2022-2027)
6.2.3 North America Piroxicam Market Size by Type (2016-2027)
6.3 North America Piroxicam Market Size by Application
6.3.1 North America Piroxicam Market Size by Application (2016-2021)
6.3.2 North America Piroxicam Market Size by Application (2022-2027)
6.3.3 North America Piroxicam Market Size by Application (2016-2027)
6.4 North America Piroxicam Market Size by Country
6.4.1 North America Piroxicam Market Size by Country (2016-2021)
6.4.2 North America Piroxicam Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Piroxicam Market Size (2016-2027)
7.2 Europe Piroxicam Market Size by Type
7.2.1 Europe Piroxicam Market Size by Type (2016-2021)
7.2.2 Europe Piroxicam Market Size by Type (2022-2027)
7.2.3 Europe Piroxicam Market Size by Type (2016-2027)
7.3 Europe Piroxicam Market Size by Application
7.3.1 Europe Piroxicam Market Size by Application (2016-2021)
7.3.2 Europe Piroxicam Market Size by Application (2022-2027)
7.3.3 Europe Piroxicam Market Size by Application (2016-2027)
7.4 Europe Piroxicam Market Size by Country
7.4.1 Europe Piroxicam Market Size by Country (2016-2021)
7.4.2 Europe Piroxicam Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Piroxicam Market Size (2016-2027)
8.2 Asia-Pacific Piroxicam Market Size by Type
8.2.1 Asia-Pacific Piroxicam Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Piroxicam Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Piroxicam Market Size by Type (2016-2027)
8.3 Asia-Pacific Piroxicam Market Size by Application
8.3.1 Asia-Pacific Piroxicam Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Piroxicam Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Piroxicam Market Size by Application (2016-2027)
8.4 Asia-Pacific Piroxicam Market Size by Region
8.4.1 Asia-Pacific Piroxicam Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Piroxicam Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Piroxicam Market Size (2016-2027)
9.2 Latin America Piroxicam Market Size by Type
9.2.1 Latin America Piroxicam Market Size by Type (2016-2021)
9.2.2 Latin America Piroxicam Market Size by Type (2022-2027)
9.2.3 Latin America Piroxicam Market Size by Type (2016-2027)
9.3 Latin America Piroxicam Market Size by Application
9.3.1 Latin America Piroxicam Market Size by Application (2016-2021)
9.3.2 Latin America Piroxicam Market Size by Application (2022-2027)
9.3.3 Latin America Piroxicam Market Size by Application (2016-2027)
9.4 Latin America Piroxicam Market Size by Country
9.4.1 Latin America Piroxicam Market Size by Country (2016-2021)
9.4.2 Latin America Piroxicam Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Piroxicam Market Size (2016-2027)
10.2 Middle East & Africa Piroxicam Market Size by Type
10.2.1 Middle East & Africa Piroxicam Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Piroxicam Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Piroxicam Market Size by Type (2016-2027)
10.3 Middle East & Africa Piroxicam Market Size by Application
10.3.1 Middle East & Africa Piroxicam Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Piroxicam Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Piroxicam Market Size by Application (2016-2027)
10.4 Middle East & Africa Piroxicam Market Size by Country
10.4.1 Middle East & Africa Piroxicam Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Piroxicam Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Piroxicam Introduction
11.1.4 Pfizer Revenue in Piroxicam Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Piroxicam Introduction
11.2.4 Teva Revenue in Piroxicam Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Piroxicam Introduction
11.3.4 Mylan Revenue in Piroxicam Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Nostrum
11.4.1 Nostrum Company Details
11.4.2 Nostrum Business Overview
11.4.3 Nostrum Piroxicam Introduction
11.4.4 Nostrum Revenue in Piroxicam Business (2016-2021)
11.4.5 Nostrum Recent Development
11.5 DCPC
11.5.1 DCPC Company Details
11.5.2 DCPC Business Overview
11.5.3 DCPC Piroxicam Introduction
11.5.4 DCPC Revenue in Piroxicam Business (2016-2021)
11.5.5 DCPC Recent Development
11.6 FANGMING
11.6.1 FANGMING Company Details
11.6.2 FANGMING Business Overview
11.6.3 FANGMING Piroxicam Introduction
11.6.4 FANGMING Revenue in Piroxicam Business (2016-2021)
11.6.5 FANGMING Recent Development
11.7 JINGHUA
11.7.1 JINGHUA Company Details
11.7.2 JINGHUA Business Overview
11.7.3 JINGHUA Piroxicam Introduction
11.7.4 JINGHUA Revenue in Piroxicam Business (2016-2021)
11.7.5 JINGHUA Recent Development
11.8 JUMPCAN
11.8.1 JUMPCAN Company Details
11.8.2 JUMPCAN Business Overview
11.8.3 JUMPCAN Piroxicam Introduction
11.8.4 JUMPCAN Revenue in Piroxicam Business (2016-2021)
11.8.5 JUMPCAN Recent Development
11.9 Technilab Pharma
11.9.1 Technilab Pharma Company Details
11.9.2 Technilab Pharma Business Overview
11.9.3 Technilab Pharma Piroxicam Introduction
11.9.4 Technilab Pharma Revenue in Piroxicam Business (2016-2021)
11.9.5 Technilab Pharma Recent Development
11.10 Apotex Corporation
11.10.1 Apotex Corporation Company Details
11.10.2 Apotex Corporation Business Overview
11.10.3 Apotex Corporation Piroxicam Introduction
11.10.4 Apotex Corporation Revenue in Piroxicam Business (2016-2021)
11.10.5 Apotex Corporation Recent Development
11.11 Keltman Pharmaceuticals
11.11.1 Keltman Pharmaceuticals Company Details
11.11.2 Keltman Pharmaceuticals Business Overview
11.11.3 Keltman Pharmaceuticals Piroxicam Introduction
11.11.4 Keltman Pharmaceuticals Revenue in Piroxicam Business (2016-2021)
11.11.5 Keltman Pharmaceuticals Recent Development
11.12 Genpharm
11.12.1 Genpharm Company Details
11.12.2 Genpharm Business Overview
11.12.3 Genpharm Piroxicam Introduction
11.12.4 Genpharm Revenue in Piroxicam Business (2016-2021)
11.12.5 Genpharm Recent Development
11.13 Bayer
11.13.1 Bayer Company Details
11.13.2 Bayer Business Overview
11.13.3 Bayer Piroxicam Introduction
11.13.4 Bayer Revenue in Piroxicam Business (2016-2021)
11.13.5 Bayer Recent Development
11.14 PLX Pharma
11.14.1 PLX Pharma Company Details
11.14.2 PLX Pharma Business Overview
11.14.3 PLX Pharma Piroxicam Introduction
11.14.4 PLX Pharma Revenue in Piroxicam Business (2016-2021)
11.14.5 PLX Pharma Recent Development
11.15 Chiesi
11.15.1 Chiesi Company Details
11.15.2 Chiesi Business Overview
11.15.3 Chiesi Piroxicam Introduction
11.15.4 Chiesi Revenue in Piroxicam Business (2016-2021)
11.15.5 Chiesi Recent Development
11.16 SK Chemicals
11.16.1 SK Chemicals Company Details
11.16.2 SK Chemicals Business Overview
11.16.3 SK Chemicals Piroxicam Introduction
11.16.4 SK Chemicals Revenue in Piroxicam Business (2016-2021)
11.16.5 SK Chemicals Recent Development
11.17 Bioglan Laboratories
11.17.1 Bioglan Laboratories Company Details
11.17.2 Bioglan Laboratories Business Overview
11.17.3 Bioglan Laboratories Piroxicam Introduction
11.17.4 Bioglan Laboratories Revenue in Piroxicam Business (2016-2021)
11.17.5 Bioglan Laboratories Recent Development
11.18 APR
11.18.1 APR Company Details
11.18.2 APR Business Overview
11.18.3 APR Piroxicam Introduction
11.18.4 APR Revenue in Piroxicam Business (2016-2021)
11.18.5 APR Recent Development
11.18 CJ HealthCare
.1 CJ HealthCare Company Details
.2 CJ HealthCare Business Overview
.3 CJ HealthCare Piroxicam Introduction
.4 CJ HealthCare Revenue in Piroxicam Business (2016-2021)
.5 CJ HealthCare Recent Development
11.20 SkyePharma
11.20.1 SkyePharma Company Details
11.20.2 SkyePharma Business Overview
11.20.3 SkyePharma Piroxicam Introduction
11.20.4 SkyePharma Revenue in Piroxicam Business (2016-2021)
11.20.5 SkyePharma Recent Development
11.21 Changzhou Siyao Pharmaceutical
11.21.1 Changzhou Siyao Pharmaceutical Company Details
11.21.2 Changzhou Siyao Pharmaceutical Business Overview
11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Introduction
11.21.4 Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2016-2021)
11.21.5 Changzhou Siyao Pharmaceutical Recent Development
11.22 Shanxi Yunpeng Pharmaceutical
11.22.1 Shanxi Yunpeng Pharmaceutical Company Details
11.22.2 Shanxi Yunpeng Pharmaceutical Business Overview
11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Introduction
11.22.4 Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2016-2021)
11.22.5 Shanxi Yunpeng Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details